Atara Biotherapeutics Stock (NASDAQ: ATRA) stock price, news, charts, stock research, profile.
Open | $8.00 |
Close | $7.79 |
Volume / Avg. | 121.64K / 133.01K |
Day Range | $7.60 - $8.11 |
52 Wk Range | 4.97 - 49.00 |
Market Cap | $43.77M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 7.33% |
Days to Cover | 6.84 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Atara Biotherapeutics (NASDAQ:ATRA) through any online brokerage.
Other companies in Atara Biotherapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Serina Therapeutics (AMEX:SER), HOOKIPA Pharma (NASDAQ:HOOK), Fortress Biotech (NASDAQ:FBIO) and Kezar Life Sciences (NASDAQ:KZR).
Atara Biotherapeutics has a consensus price target of $13.77.
The stock price for Atara Biotherapeutics (NASDAQ: ATRA) is $7.715 last updated September 20, 2024 at 6:02 PM EDT.
There are no upcoming dividends for Atara Biotherapeutics.
Atara Biotherapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Atara Biotherapeutics.
Atara Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.